Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia

Journal of Immunology

Volumn 182, Issue 10, 2009, Pages 5938-5948

  Zheng, Hong ^a   Matte Martone, Catherine ^b   Jain, Dhanpat ^c   McNiff, Jennifer ^c   Shlomchik, Warren D ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b YALE CANCER CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ENTEROPATHY; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HISTOLOGY; LIVER DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN DISEASE; T LYMPHOCYTE;

ANIMALS; BONE MARROW TRANSPLANTATION; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOLOGIC MEMORY; LEUKEMIA, EXPERIMENTAL; MICE; T-LYMPHOCYTE SUBSETS;

EID: 77951160869     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802212     Document Type: Article

References (97)

1. Mackall, C. L., and R. E. Gress. 1997. Pathways of T cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol. Rev. 157: 61-72.
2. Collins, R. H., Jr., O. Shpilberg, W. R. Drobyski, D. L. Porter, S. Giralt, R. Champlin, S. A. Goodman, S. N. Wolff, W. Hu, C. Verfaillie, et al. 1997. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J. Clin. Oncol. 15: 433-444.
3. Kolb, H. J., A. Schattenberg, J. M. Goldman, B. Hertenstein, N. Jacobsen, W. Arcese, P. Ljungman, A. Ferrant, L. Verdonck, D. Niederwieser, et al. 1995. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 86: 2041-2050.
4. Porter, D. L., R. H. Collins, Jr., O. Shpilberg, W. R. Drobyski, J. M. Connors, A. Sproles, and J. H. Antin. 1999. Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions. Biol. Blood Marrow Transplant. 5: 253-261.
5. Horowitz, M. M., R. P. Gale, P. M. Sondel, J. M. Goldman, J. Kersey, H. J. Kolb, A. A. Rimm, O. Ringden, C. Rozman, B. Speck, et al. 1990. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75: 555-562.
6. Sprent, J., and C. D. Surh. 2001. Generation and maintenance of memory T cells. Curr. Opin. Immunol. 13: 248-254.
7. Berard, M., and D. F. Tough. 2002. Qualitative differences between naive and memory T cells. Immunology 106: 127-138.
8. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions [see comments]. Nature 401: 708-712.
9. Sallusto, F., C. R. Mackay, and A. Lanzavecchia. 2000. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18: 593-620.
10. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22: 745-763.
11. Wherry, E. J., V. Teichgraber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4: 225-234.
12. Kalia, V., S. Sarkar, T. S. Gourley, B. T. Rouse, and R. Ahmed. 2006. Differentiation of memory B and T cells. Curr. Opin. Immunol. 18: 255-264.
13. Masopust, D., V. Vezys, E. J. Wherry, and R. Ahmed. 2007. A brief history of CD8 T cells. Eur. J. Immunol. 37(Suppl. 1): S103-S110.
14. + T cells. J. Exp. Med. 194: 953-966.
15. Bouneaud, C., Z. Garcia, P. Kourilsky, and C. Pannetier. 2005. Lineage relationships, homeostasis, and recall capacities of central- and effector-memory CD8 T cells in vivo. J. Exp. Med. 201: 579-590.
16. Zaph, C., J. Uzonna, S. M. Beverley, and P. Scott. 2004. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat. Med. 10: 1104-1110.
17. + T cells confer superior antitumor immunity compared with effector memory T cells. Proc. Natl. Acad. Sci. USA 102: 9571-9576.
18. + T cells derived from central memory cells establishes persistent T cell memory in primates. J. Clin. Invest. 118: 294-305.
19. + T cells for effective immunotherapy. Curr. Opin. Immunol. 18: 363-370.
20. Lefrancois, L. 2006. Development, trafficking, and function of memory T cell subsets. Immunol. Rev. 211: 93-103.
21. Roberts, A. D., K. H. Ely, and D. L. Woodland. 2005. Differential contributions of central and effector memory T cells to recall responses. J. Exp. Med. 202: 123-133.
22. + T cells do not induce graft-versus-host disease. J. Clin. Invest. 112: 101-108.
23. Beilhack, A., S. Schulz, J. Baker, G. F. Beilhack, C. B. Wieland, E. I. Herman, E. M. Baker, Y. A. Cao, C. H. Contag, and R. S. Negrin. 2005. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T cell subsets. Blood 106: 1113-1122.
24. - memory T cells without graft-versus-host disease. Blood 103: 1534-1541.
25. + T cells are defective in mediating acute graft-versus-host disease but retain graft-versus-leukemia activity. Blood 103: 3970-3978.
26. + T cells mediate graft-versus-leukemia without inducing graft-versus-host disease. Blood 111: 2476-2484.
27. Chen, B. J., D. Deoliveira, X. Cui, N. T. Le, J. Son, J. F. Whitesides, and N. J. Chao. 2007. Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse. Blood 109: 3115-3123.
28. Matte, C. C., J. Liu, J. Cormier, B. E. Anderson, I. Athanasiadis, D. Jain, J. McNiff, and W. D. Shlomchik. 2004. Donor APCs are required for maximal GVHD but not for GVL. Nat. Med. 10: 987-992.
29. Matte, C. C., J. Cormier, B. E. Anderson, I. Athanasiadis, J. Liu, S. G. Emerson, W. Pear, and W. D. Shlomchik. 2004. Graft-versus-leukemia in a retrovirally induced murine CML model: mechanisms of T cell killing. Blood 103: 4353-4361.
30. Shlomchik, W. D., M. S. Couzens, C. B. Tang, J. McNiff, M. E. Robert, J. Liu, M. J. Shlomchik, and S. G. Emerson. 1999. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285: 412-415.
31. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7: 1063-1066.
32. Pear, W. S., J. P. Miller, L. Xu, J. C. Pui, B. Soffer, R. C. Quackenbush, A. M. Pendergast, R. Bronson, J. C. Aster, M. L. Scott, and D. Baltimore. 1998. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 92: 3780-3792.
33. Li, S., R. L. Ilaria, Jr., R. P. Million, G. Q. Daley, and R. A. Van Etten. 1999. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J. Exp. Med. 189: 1399-1412.
34. Shlomchik, W. D., and C. C. Matte-Martone. 2006. Leukemia-specific antigens alone are insufficient for GVL in MHC-matched allogeneic stem cell transplantation: An essential role for minor H antigens. Blood 108: 59A-60A.
35. 7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus- host disease. Blood 106: 4009-4015.
36. Dutt, S., D. Tseng, J. Ermann, T. I. George, Y. P. Liu, C. R. Davis, C. G. Fathman, and S. Strober. 2007. Naive and memory T cells induce different types of graft-versus-host disease. J. Immunol. 179: 6547-6554.
37. Fox, J. G. 2002. Laboratory Animal Medicine. Academic Press, New York.
38. Fox, J. G. 2007. The Mouse in Biomedical Research. Elsevier, Boston.
39. Foltz, C. J., J. G. Fox, R. Cahill, J. C. Murphy, L. Yan, B. Shames, and D. B. Schauer. 1998. Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter 3: 69-78.
40. Fox, J. G., L. L. Yan, F. E. Dewhirst, B. J. Paster, B. Shames, J. C. Murphy, A. Hayward, J. C. Belcher, and E. N. Mendes. 1995. Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J. Clin. Microbiol. 33: 445-454.
41. Pappo, J., D. Torrey, L. Castriotta, A. Savinainen, Z. Kabok, and A. Ibraghimov. 1999. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect. Immun. 67: 337-341.
42. Shames, B., J. G. Fox, F. Dewhirst, L. Yan, Z. Shen, and N. S. Taylor. 1995. Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay. J. Clin. Microbiol. 33: 2968-2972.
43. Min, B., G. Foucras, M. Meier-Schellersheim, and W. E. Paul. 2004. Spontaneous proliferation, a response of naive CD4 T cells determined by the diversity of the memory cell repertoire. Proc. Natl. Acad. Sci. USA 101: 3874-3879.
44. Min, B., H. Yamane, J. Hu-Li, and W. E. Paul. 2005. Spontaneous and homeostatic proliferation of CD4 T cells are regulated by different mechanisms. J. Immunol. 174: 6039-6044.
45. Surh, C. D., and J. Sprent. 2006. On the TRAIL of homeostatic memory T cells. Nat. Immunol. 7: 439-441.
46. + T cells. Nat. Immunol. 7: 475-481.
47. Lombardi, G., S. Sidhu, M. Daly, J. R. Batchelor, W. Makgoba, and R. I. Lechler. 1990. Are primary alloresponses truly primary? Int. Immunol. 2: 9-13.
48. Heeger, P. S., N. S. Greenspan, S. Kuhlenschmidt, C. Dejelo, D. E. Hricik, J. A. Schulak, and M. Tary-Lehmann. 1999. Pretransplant frequency of donor-specific, IFN-γ-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J. Immunol. 163: 2267-2275.
49. O'Brien, R. M., and D. M. Kemeny. 1998. Distribution of alloreactivity amongst the CD45 isoforms of circulating CD4 and CD8 T lymphocytes. Scand. J. Immunol. 48: 679-683.
50. Epperson, D. E., and J. S. Pober. 1994. Antigen-presenting function of human endothelial cells: direct activation of resting CD8 T cells. J. Immunol. 153: 5402-5412.
51. Taylor, D. K., D. Neujahr, and L. A. Turka. 2004. Heterologous immunity and homeostatic proliferation as barriers to tolerance. Curr. Opin. Immunol. 16: 558-564.
52. Adams, A. B., T. C. Pearson, and C. P. Larsen. 2003. Heterologous immunity: an overlooked barrier to tolerance. Immunol. Rev. 196: 147-160.
53. Pantenburg, B., F. Heinzel, L. Das, P. S. Heeger, and A. Valujskikh. 2002. T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J. Immunol. 169: 3686-3693.
54. Brehm, M. A., T. G. Markees, K. A. Daniels, D. L. Greiner, A. A. Rossini, and R. M. Welsh. 2003. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J. Immunol. 170: 4077-4086.
55. Adams, A. B., M. A. Williams, T. R. Jones, N. Shirasugi, M. M. Durham, S. M. Kaech, E. J. Wherry, T. Onami, J. G. Lanier, K. E. Kokko, et al. 2003. Heterologous immunity provides a potent barrier to transplantation tolerance. J. Clin. Invest. 111: 1887-1895.
56. Williams, M. A., T. M. Onami, A. B. Adams, M. M. Durham, T. C. Pearson, R. Ahmed, and C. P. Larsen. 2002. Cutting edge: persistent viral infection prevents tolerance induction and escapes immune control following CD28/CD40 blockade-based regimen. J. Immunol. 169: 5387-5391.
57. Burrows, S. R., R. Khanna, J. M. Burrows, and D. J. Moss. 1994. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J. Exp. Med. 179: 1155-1161.
58. Burrows, S. R., R. Khanna, S. L. Silins, and D. J. Moss. 1999. The influence of antiviral T cell responses on the alloreactive repertoire. Immunol. Today 20: 203-207.
59. Bingaman, A. W., and D. L. Farber. 2004. Memory T cells in transplantation: generation, function, and potential role in rejection. Am. J. Transplant. 4: 846-852.
60. Nahill, S. R., and R. M. Welsh. 1993. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J. Exp. Med. 177: 317-327.
61. Welsh, R. M., and L. K. Selin. 2002. No one is naive: the significance of heterologous T cell immunity. Nat. Rev. Immunol. 2: 417-426.
62. Ashwell, J. D., C. Chen, and R. H. Schwartz. 1986. High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self-class II molecules. J. Immunol. 136: 389-395.
63. Selin, L. K., S. R. Nahill, and R. M. Welsh. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 179: 1933-1943.
64. Selin, L. K., S. M. Varga, I. C. Wong, and R. M. Welsh. 1998. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 188: 1705-1715.
65. Welsh, R. M., J. M. McNally, M. A. Brehm, and L. K. Selin. 2000. Consequences of cross-reactive and bystander CTL responses during viral infections. Virology 270: 4-8.
66. + T cells in heterologous antiviral immunity and immunopathology in the lung. Nat. Immunol. 2: 1067-1076.
67. Kim, S. K., M. A. Brehm, R. M. Welsh, and L. K. Selin. 2002. Dynamics of memory T cell proliferation under conditions of heterologous immunity and bystander stimulation. J. Immunol. 169: 90-98.
68. Selin, L. K., M. Cornberg, M. A. Brehm, S. K. Kim, C. Calcagno, D. Ghersi, R. Puzone, F. Celada, and R. M. Welsh. 2004. CD8 memory T cells: cross-reactivity and heterologous immunity. Semin. Immunol. 16: 335-347.
69. Welsh, R. M., L. K. Selin, and E. Szomolanyi-Tsuda. 2004. Immunological memory to viral infections. Annu. Rev. Immunol. 22: 711-743.
70. + T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. J. Clin. Invest. 115: 3602-3612.
71. Kim, S. K., M. Cornberg, X. Z. Wang, H. D. Chen, L. K. Selin, and R. M. Welsh. 2005. Private specificities of CD8 T cell responses control patterns of heterologous immunity. J. Exp. Med. 201: 523-533.
72. Cornberg, M., A. T. Chen, L. A. Wilkinson, M. A. Brehm, S. K. Kim, C. Calcagno, D. Ghersi, R. Puzone, F. Celada, R. M. Welsh, and L. K. Selin. 2006. Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity. J. Clin. Invest. 116: 1443-1456.
73. + T cell cross-reactivity and heterologous immunity. Immunol. Rev. 211: 164-181.
74. Wu, Z., S. J. Bensinger, J. Zhang, C. Chen, X. Yuan, X. Huang, J. F. Markmann, A. Kassaee, B. R. Rosengard, W. W. Hancock, et al. 2004. Homeostatic proliferation is a barrier to transplantation tolerance. Nat. Med. 10: 87-92.
75. + T cell response to infection. Immunity 26: 827-841.
76. + T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281-295.
77. Korngold, R., and J. Sprent. 1990. T cell subsets and graft-vs-host disease. In Graft-vs-Host Disease. S. J. Burakoff, H. J. Deeg, J. Ferrara, and K. Atkinson, eds. Marcel Dekker, New York, pp 31-50.
78. Fecteau, S., G. P. Basadonna, A. Freitas, C. Ariyan, M. H. Sayegh, and D. M. Rothstein. 2001. CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat. Immunol. 2: 58-63.
79. + central and effector memory T cell subsets are largely distinct. Immunity 18: 193-204.
80. Anderson, B. E., P. A. Taylor, J. M. McNiff, D. Jain, A. J. Demetris, A. Panoskaltsis-Mortari, A. Ager, B. R. Blazar, W. D. Shlomchik, and M. J. Shlomchik. 2008. Effects of donor T cell trafficking and priming site on GVHD induction by naive and memory phenotype CD4 T cells. Blood 111: 5242-5251.
81. Beilhack, A., S. Schulz, J. Baker, G. F. Beilhack, R. Nishimura, E. M. Baker, G. Landan, E. I. Herman, E. C. Butcher, C. H. Contag, and R. S. Negrin. 2008. Prevention of acute graft-versus-host disease by blocking T cell entry to secondary lymphoid organs. Blood 111: 2919-2928.
82. + T cells. Immunity 22: 259-270.
83. + T cell differentiation in response to viruses. Nat. Rev. Immunol. 3: 931-939.
84. Gamadia, L. E., E. M. van Leeuwen, E. B. Remmerswaal, S. L. Yong, S. Surachno, P. M. Wertheim-van Dillen, I. J. Ten Berge, and R. A. Van Lier. 2004. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J. Immunol. 172: 6107-6114.
85. + T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8: 379-385.
86. Arstila, T. P., A. Casrouge, V. Baron, J. Even, J. Kanellopoulos, and P. Kourilsky. 1999. A direct estimate of the human αβ T cell receptor diversity. Science 286: 958-961.
87. + T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27: 203-213.
88. Choi, E. Y., G. J. Christianson, Y. Yoshimura, T. J. Sproule, N. Jung, S. Joyce, and D. C. Roopenian. 2002. Immunodominance of H60 is caused by an abnormally high precursor T cell pool directed against its unique minor histocompatibility antigen peptide. Immunity 17: 593-603.
89. Friedman, T. M., K. Goldgirsh, S. A. Berger, J. Zilberberg, J. Filicko-O'Hara, N. Flomenberg, M. Donato, S. D. Rowley, and R. Korngold. 2008. Overlap between in vitro donor anti-host and in vivo post-transplantation TCR Vβ utilization: a new paradigm for designer allogeneic blood and marrow transplantation. Blood 112: 3517-3525.
90. Zilberberg, J., D. McElhaugh, L. N. Gichuru, R. Korngold, and T. M. Friedman. 2008. Inter-strain tissue-infiltrating T cell responses to minor histocompatibility antigens involved in graft-versus-host disease as determined by Vβ spectratype analysis. J. Immunol. 180: 5352-5359.
91. + T cells mediating graft-versus-host disease directed to minor histocompatibility antigens. Biol Blood Marrow Transplant. 13: 265-276.
92. Wettstein, P. J., and D. W. Bailey. 1982. Immunodominance in the immune response to "multiple" histocompatibility antigens. Immunogenetics 16: 47-58.
93. Korngold, R., and P. J. Wettstein. 1990. Immunodominance in the graft-vs-host disease T cell response to minor histocompatibility antigens. J. Immunol. 145: 4079-4088.
94. Choi, E. Y., G. J. Christianson, Y. Yoshimura, N. Jung, T. J. Sproule, S. Malarkannan, S. Joyce, and D. C. Roopenian. 2002. Real-time T cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease. Blood 100: 4259-4265.
95. Krenger, W., and J. L. Ferrara. 1996. Graft-versus-host disease and the Th1/Th2 paradigm. Immunol. Res. 15: 50-73.
96. van den Brink, M. R., and S. J. Burakoff. 2002. Cytolytic pathways in haematopoietic stem-cell transplantation. Nat. Rev. Immunol. 2: 273-281.
97. Shlomchik, W. D. 2007. Graft-versus-host disease. Nat Rev Immunol. 7: 340-352.